These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10146885)

  • 1. The reliability of cost-utility estimates in cost-per-QALY league tables .
    Petrou S; Malek M; Davey PG
    Pharmacoeconomics; 1993 May; 3(5):345-53. PubMed ID: 10146885
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-per-QALY league tables: their role in pharmacoeconomic analysis.
    Mason JM
    Pharmacoeconomics; 1994 Jun; 5(6):472-81. PubMed ID: 10147264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QALY league tables: handle with care.
    Gerard K; Mooney G
    Health Econ; 1993 Apr; 2(1):59-64. PubMed ID: 8269048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QALY league tables revisited.
    Gudex CM
    Pharmacoeconomics; 1993 May; 3(5):425-6. PubMed ID: 10146891
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-utility analysis.
    Robinson R
    BMJ; 1993 Oct; 307(6908):859-62. PubMed ID: 8401133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some guidelines on the use of cost effectiveness league tables.
    Mason J; Drummond M; Torrance G
    BMJ; 1993 Feb; 306(6877):570-2. PubMed ID: 8461776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The QALY--a measure of social value rather than individual utility?
    Nord E
    Health Econ; 1994; 3(2):89-93. PubMed ID: 8044215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility in practice: a policy maker's guide to the state of the art.
    Gerard K
    Health Policy; 1992 Jul; 21(3):249-79. PubMed ID: 10120196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness league tables: more harm than good?
    Drummond M; Torrance G; Mason J
    Soc Sci Med; 1993 Jul; 37(1):33-40. PubMed ID: 8332922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myth of the HYE (healthy year equivalent).
    Loomes G
    J Health Econ; 1995 May; 14(1):1-7. PubMed ID: 10143484
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QALYs, standard gambles, and the expected budget constraint.
    Blomqvist A
    J Health Econ; 2002 Mar; 21(2):181-95. PubMed ID: 11939237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing the QALY concept: exploring the problems of data acquisition.
    Coast J
    Pharmacoeconomics; 1993 Oct; 4(4):240-6. PubMed ID: 10146913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
    Wasem J; Hessel F; Kerim-Sade C
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QALY league tables.
    Jefferson T; Mugford M; Demicheli V
    Health Econ; 1994; 3(3):205. PubMed ID: 7921063
    [No Abstract]   [Full Text] [Related]  

  • 16. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost utility analysis: 'new directions' in setting health care priorities.
    Richardson J; Cook J
    Aust Health Rev; 1992; 15(2):145-54. PubMed ID: 10119046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for assessing relative importance in preference based outcome measures.
    Kaplan RM; Feeny D; Revicki DA
    Qual Life Res; 1993 Dec; 2(6):467-75. PubMed ID: 8161981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataract surgery cost utility revisited in 2012: a new economic paradigm.
    Brown GC; Brown MM; Menezes A; Busbee BG; Lieske HB; Lieske PA
    Ophthalmology; 2013 Dec; 120(12):2367-2376. PubMed ID: 24246824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.